Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962.
D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D009369:Neoplasms / Q000532:radiotherapy
D000477:Alkylating Agents; D000970:Antineoplastic Agents